Cargando…

TMEM16A/ANO1: Current Strategies and Novel Drug Approaches for Cystic Fibrosis

Cystic fibrosis (CF) is the most common of rare hereditary diseases in Caucasians, and it is estimated to affect 75,000 patients globally. CF is a complex disease due to the multiplicity of mutations found in the CF transmembrane conductance regulator (CFTR) gene causing the CFTR protein to become d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mitri, Christie, Sharma, Himanshu, Corvol, Harriet, Tabary, Olivier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616501/ https://www.ncbi.nlm.nih.gov/pubmed/34831090 http://dx.doi.org/10.3390/cells10112867

Ejemplares similares

Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
por: Mitri, Christie, et al.
Publicado: (2020)

Emerging microRNA Therapeutic Approaches for Cystic Fibrosis
por: Bardin, Pauline, et al.
Publicado: (2018)

MicroRNA-9 downregulates the ANO1 chloride channel and contributes to cystic fibrosis lung pathology
por: Sonneville, Florence, et al.
Publicado: (2017)

TMEM16A in Cystic Fibrosis: Activating or Inhibiting?
por: Kunzelmann, Karl, et al.
Publicado: (2019)

The role of TMEM16A (ANO1) and TMEM16F (ANO6) in cell migration
por: Jacobsen, K. S., et al.
Publicado: (2013)

miR-636: A Newly-Identified Actor for the Regulation of Pulmonary Inflammation in Cystic Fibrosis
por: Bardin, Pauline, et al.
Publicado: (2019)

TMEM16A: An Alternative Approach to Restoring Airway Anion Secretion in Cystic Fibrosis?
por: Danahay, Henry, et al.
Publicado: (2020)

TMEM16A Potentiation: A Novel Therapeutic Approach for the Treatment of Cystic Fibrosis
por: Danahay, Henry L., et al.
Publicado: (2020)

TMEM16A Potentiators: Is There a Need for New Modulators in Cystic Fibrosis?
por: Kim, Michael D., et al.
Publicado: (2020)

Opposite Expression of Hepatic and Pulmonary Corticosteroid-Binding Globulin in Cystic Fibrosis Patients
por: Tchoukaev, Anastasia, et al.
Publicado: (2018)

Normal and Cystic Fibrosis Human Bronchial Epithelial Cells Infected with Pseudomonas aeruginosa Exhibit Distinct Gene Activation Patterns
por: Balloy, Viviane, et al.
Publicado: (2015)

Glucocorticoid receptor gene polymorphisms associated with progression of lung disease in young patients with cystic fibrosis
por: Corvol, Harriet, et al.
Publicado: (2007)

ANO1 (TMEM16A) in pancreatic ductal adenocarcinoma (PDAC)
por: Sauter, D. R. P., et al.
Publicado: (2014)

Does calmodulin regulate the bicarbonate permeability of ANO1/TMEM16A or not?
por: Jung, Jinsei, et al.
Publicado: (2015)

Identification of a lipid scrambling domain in ANO6/TMEM16F
por: Yu, Kuai, et al.
Publicado: (2015)

Gating and anion selectivity are reciprocally regulated in TMEM16A (ANO1)
por: De Jesús-Pérez, José J., et al.
Publicado: (2022)

Modifier Factors of Cystic Fibrosis Phenotypes: A Focus on Modifier Genes
por: Mésinèle, Julie, et al.
Publicado: (2022)

The Anion Channel TMEM16a/Ano1 Modulates CFTR Activity, but Does Not Function as an Apical Anion Channel in Colonic Epithelium from Cystic Fibrosis Patients and Healthy Individuals
por: Salari, Azam, et al.
Publicado: (2023)

Activation of the Ano1 (TMEM16A) chloride channel by calcium is not mediated by calmodulin
por: Yu, Kuai, et al.
Publicado: (2014)

Factors Predisposing the Response to Lumacaftor/Ivacaftor in People with Cystic Fibrosis
por: Mésinèle, Julie, et al.
Publicado: (2022)

Proinflammatory cytokine secretion is suppressed by TMEM16A or CFTR channel activity in human cystic fibrosis bronchial epithelia
por: Veit, Guido, et al.
Publicado: (2012)

Calcium-Activated Chloride Channel ANO1/TMEM16A: Regulation of Expression and Signaling
por: Dulin, Nickolai O.
Publicado: (2020)

Flagellin concentrations in expectorations from cystic fibrosis patients
por: Balloy, Viviane, et al.
Publicado: (2014)

Achromobacter xylosoxidans airway infection is associated with lung disease severity in children with cystic fibrosis
por: Marsac, Charlotte, et al.
Publicado: (2021)

The Ca(2+)-activated Cl(−) channel ANO1/TMEM16A regulates primary ciliogenesis
por: Ruppersburg, Chelsey Chandler, et al.
Publicado: (2014)

A Pore Idea: the ion conduction pathway of TMEM16/ANO proteins is composed partly of lipid
por: Whitlock, Jarred M., et al.
Publicado: (2016)

ANO1/TMEM16A regulates process maturation in radial glial cells in the developing brain
por: Hong, Gyu-Sang, et al.
Publicado: (2019)

Cystic Fibrosis Liver Disease: Outcomes and Risk Factors in a Large Cohort of French Patients
por: Boëlle, Pierre‐Yves, et al.
Publicado: (2018)

AGER -429T/C Is Associated with an Increased Lung Disease Severity in Cystic Fibrosis
por: Beucher, Julie, et al.
Publicado: (2012)

Purified human brain calmodulin does not alter the bicarbonate permeability of the ANO1/TMEM16A channel
por: Yu, Yawei, et al.
Publicado: (2015)

Purified human brain calmodulin does not alter the bicarbonate permeability of the ANO1/TMEM16A channel
por: Yu, Yawei, et al.
Publicado: (2015)

Inhibition of ANO1/TMEM16A Chloride Channel by Idebenone and Its Cytotoxicity to Cancer Cell Lines
por: Seo, Yohan, et al.
Publicado: (2015)

Development of the Olfactory Epithelium and Nasal Glands in TMEM16A(-/-) and TMEM16A(+/+) Mice
por: Maurya, Devendra Kumar, et al.
Publicado: (2015)

Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far?
por: Plocque, Alexia, et al.
Publicado: (2022)

Mechanism of allosteric activation of TMEM16A/ANO1 channels by a commonly used chloride channel blocker
por: Ta, Chau M, et al.
Publicado: (2016)

AB095. Increased expression of TMEM16A/Ano1 chloride channel associated with diabetic erectile dysfunction
por: Ruan, Yajun, et al.
Publicado: (2016)

ANO1/TMEM16A interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancer
por: Bill, Anke, et al.
Publicado: (2015)

Gain of function of TMEM16E/ANO5 scrambling activity caused by a mutation associated with gnathodiaphyseal dysplasia
por: Di Zanni, Eleonora, et al.
Publicado: (2017)

ANO9/TMEM16J promotes tumourigenesis via EGFR and is a novel therapeutic target for pancreatic cancer
por: Jun, Ikhyun, et al.
Publicado: (2017)

SLC26A9 Gene Is Associated With Lung Function Response to Ivacaftor in Patients With Cystic Fibrosis
por: Corvol, Harriet, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tkr98otdr86q3lbhst68fp2bd4